| AI | Artificial intelligence |
| AUC | Area under the curve |
| CAF | Cancer-associated fibroblast |
| CT | Computed tomography |
| DPP4 | Dipeptidyl peptidase IV |
| EANM | European Association of Nuclear Medicine |
| EMT | Epithelial–mesenchymal transition |
| FAP | Fibroblast activation protein |
| FAPI | Fibroblast activation protein inhibitor |
| FAP-RADS | Fibroblast Activation Protein Reporting and Data System |
| FDG | Fluorodeoxyglucose |
| HCC | Hepatocellular carcinoma |
| HNSCC | Head and neck squamous cell carcinoma |
| ICC | Intrahepatic cholangiocarcinoma |
| LAFOV | Long axial field-of-view |
| MRI | Magnetic resonance imaging |
| NSCLC | Non-small cell lung cancer |
| PDAC | Pancreatic ductal adenocarcinoma |
| PET | Positron emission tomography |
| PRISMA-ScR | Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews |
| QA | Quality assurance |
| QC | Quality control |
| RLT | Radioligand therapy |
| SiPM | Silicon photomultiplier |
| SNMMI | Society of Nuclear Medicine and Molecular Imaging |
| SPECT | Single photon emission computed tomography |
| SUV | Standardized uptake value |
| SUVmax | Maximum standardised uptake value |
| TBR | Tumor-to-background ratio |
| TME | Tumor microenvironment |